Clinical Trial Update: A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert [Phase 3]

View source ↗

Summary

Phase 3 study completed evaluating the long-term safety of the sustained-release travoprost intracanalicular insert (OTX-TP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• OTX-TP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Open Angle Glaucoma and Ocular Hypertension | Phase 3 | Status: COMPLETED